| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.10B | -3.7% |
| Cost of Revenue | $675.9M | -4.2% |
| Gross Profit | $423.3M | -3.0% |
| R&D Expense | $10.1M | -39.5% |
| SG&A Expense | $282.8M | -15.9% |
| Operating Income | $72.2M | -23.4% |
| Interest Expense | $35.6M | +118.4% |
| Pre-tax Income | $28.3M | -86.7% |
| Income Tax | $24.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $334.4M | -1.1% |
| Inventory | $151.9M | -5.1% |
| Current Assets | $684.2M | -4.0% |
| Total Assets | $2.65B | -10.8% |
| Current Liabilities | $211.5M | -44.2% |
| Long-term Debt | $790.7M | -19.0% |
| Total Liabilities | $1.23B | -25.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $29.4M | +56.4% |
| Financing Cash Flow | -$368.0M | -159.5% |
| -29.9% |
| Net Income | $205.1M | +15.7% |
| EPS (Basic) | $9.86 | +14.7% |
| EPS (Diluted) | $9.83 | +15.2% |
| Stockholders' Equity |
| $1.40B |
| +10.1% |